hVIVO #HVO – CEO & CFO Share Purchases December 15, 2025 – Posted in: Blog, hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that on 15 December 2025, Yamin ‘Mo’ Khan, Chief Executive Officer and Stephen Pinkerton, Chief Financial Officer, purchased shares in the Company as detailed below: Director Number of ordinary shares purchased Purchase price Resultant holding Resultant holding as a % of the issued share capital Yamin ‘Mo’ Khan 3,310,405 6.04p 8,322,008 1.21% Stephen Pinkerton 520,000 5.5p 1,270,596*…

Open Orphan #ORPH – CFO appointment & change of Board roles October 18, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan #ORPH (to be renamed hVIVO plc (Ticker: HVO) effective 26 October 2022), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces the appointment of Stephen Pinkerton as Chief Financial Officer (“CFO”) and as an Executive Director, effective with immediate effect. Stephen will succeed Leo Toole who steps down from the Board and CFO role to pursue other interests. Leo…

hVIVO #HVO – CEO & CFO Share Purchases December 15, 2025 – Posted in: Blog, hVIVO (HVO)

Open Orphan #ORPH – CFO appointment & change of Board roles October 18, 2022 – Posted in: Blog, Open Orphan (ORPH)

Address

Contact

Social

LEGAL